PRKCB and atrial fibrillation: Interleukin-17A contributes to the development of AF by promoting inflammation and cardiac fibrosis (27) and affecting protein kinase C (PKC)-β and Erk 1/2 phosphorylation, as well as nuclear factor (NF)-κB activation in fibroblasts from model mice (28).